Jean-Marc Treluyer
Overview
Explore the profile of Jean-Marc Treluyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
251
Citations
5140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chouchana L, Collier M, Martin C, Burgel P, Treluyer J
J Cyst Fibros
. 2025 Mar;
PMID: 40058987
Objectives: Recent therapeutic advances, mainly with the advent of CFTR modulators, have been associated with an increasing number of pregnancies in females with cystic fibrosis (fwCF). This study aimed to...
2.
Corsia A, Joseph L, Beeker N, Manceau S, Driessen M, Meunier B, et al.
Br J Haematol
. 2025 Feb;
PMID: 39984807
This nationwide cohort study provides a comprehensive overview of maternal and perinatal outcomes associated with sickle cell disease (SCD) during pregnancy. Using the French national health database, all singleton pregnancy-related...
3.
Faure-Bardon V, Bouazza N, Benaboud S, Foissac F, Rouillon S, Froelicher-Bournaud L, et al.
J Antimicrob Chemother
. 2025 Jan;
80(3):760-766.
PMID: 39810739
Background: In cases of maternal primary infection with cytomegalovirus (CMV-MPI) maternal treatment with oral valaciclovir 8 g/day has been shown to reduce the risk of fetal infection. The pharmacological profile...
4.
Henry A, Santulli P, Bourdon M, Maignien C, Chapron C, Treluyer J, et al.
Hum Reprod Open
. 2025 Jan;
2025(1):hoae072.
PMID: 39807112
Study Question: Is there an association between dydrogesterone exposure during early pregnancy and the reporting of birth defects? Summary Answer: This observational analysis based on global safety data showed an...
5.
Thy M, Kecili F, Urien S, Bouazza N, Foissac F, Froelicher Bournaud L, et al.
Expert Opin Drug Metab Toxicol
. 2024 Dec;
:1-9.
PMID: 39692096
Background: Limited data exist on how continuous renal replacement therapy (CRRT) affects antimicrobial dosing in pediatric patients. This study examined the impact of pediatric CRRT parameters on the pharmacokinetics (PK)...
6.
Tisseyre M, Collier M, Beeker N, Kaguelidou F, Treluyer J, Chouchana L
Drug Saf
. 2024 Dec;
48(3):265-277.
PMID: 39630354
Introduction And Objective: Proton pump inhibitor (PPI) use in children increases the risk of infections, prompting inquiry into the impact of prenatal PPIs exposure on serious infections in offspring. As...
7.
Padavia F, Treluyer J, Cambonie G, Flamant C, Rideau A, Tauzin M, et al.
Clin Pharmacokinet
. 2024 Nov;
63(12):1689-1700.
PMID: 39578300
Aims: Our aim was to describe the pharmacokinetics of paracetamol and its metabolites in extreme preterm neonates in the context of patent ductus arteriosus treatment. Factors associated with inter-individual variability...
8.
Zheng Y, Rouillon S, Khemakhem M, Balakirouchenane D, Lui G, Abdalla S, et al.
J Pharm Biomed Anal
. 2024 Jul;
248:116322.
PMID: 38964167
Cystic fibrosis is one of the most common genetic diseases among caucasian population. This disease is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene encoding for...
9.
Molimard A, Foissac F, Bouazza N, Gana I, Benaboud S, Froelicher L, et al.
Br J Clin Pharmacol
. 2024 Apr;
90(8):1900-1910.
PMID: 38664899
Aims: Vigabatrin is an antiepileptic drug used to treat some forms of severe epilepsy in children. The main adverse effect is ocular toxicity, which is related to the cumulative dose....
10.
Tisseyre M, Collier M, Beeker N, Kaguelidou F, Treluyer J, Chouchana L
Drug Saf
. 2024 Feb;
47(5):453-464.
PMID: 38409516
Introduction And Objective: Given the high prevalence of antibiotic prescription during pregnancy in France and previous studies suggesting an increased risk of infection in offspring with such exposures, our study...